Cargando…
Update and critical appraisal of the use of topical azithromycin ophthalmic 1% (AzaSite(®)) solution in the treatment of ocular infections
Azithromycin is an azalide that acts by binding to the 50S ribosomal subunit of susceptible microorganisms and interfering with microbial protein synthesis. Azithromycin is also noted by anti-inflammatory and immunomodulatory activity. AzaSite(®) (Inspire Pharmaceuticals, Inc, Durham, NC) is azithro...
Autor principal: | Utine, Canan Asli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3130918/ https://www.ncbi.nlm.nih.gov/pubmed/21750614 http://dx.doi.org/10.2147/OPTH.S13785 |
Ejemplares similares
-
Review of Azithromycin Ophthalmic 1% Solution (AzaSite(®)) for the Treatment of Ocular Infections
por: Opitz, Dominick L., et al.
Publicado: (2012) -
Development of lacrimal gland organoids from iPSC derived multizonal ocular cells
por: Asal, Melis, et al.
Publicado: (2023) -
Clinical development of 1% azithromycin in DuraSite(®), a topical azalide anti-infective for ocular surface therapy
por: Friedlaender, Mitchell H, et al.
Publicado: (2007) -
A novel lidocaine hydrochloride ophthalmic gel for topical ocular anesthesia
por: Shah, HR, et al.
Publicado: (2010) -
Patient considerations in ocular hypertension: role of bimatoprost ophthalmic solution
por: Lee, Daniel, et al.
Publicado: (2017)